Linshom Management
Developer of a wearable, non‑invasive respiratory monitoring system that uses a temperature‑based thermal sensor to deliver continuous, operating‑room quality respiratory data (respiratory rate, seconds‑since‑last‑breath, and trend of relative tidal volume) at the patient bedside. The company has FDA 510(k) clearance for its respiratory monitor, has active clinical studies (ClinicalTrials.gov registrations), a portfolio of international patents, and publishes peer‑reviewed evidence supporting the technology.
Industries
Nr. of Employees
small (1-50)
Linshom Management
Products
Continuous predictive respiratory monitoring system (wearable thermal sensor with control unit and monitor)
A bedside system comprising a disposable thermal sensor, control unit, and monitor that continuously measures and displays respiratory rate, seconds‑since‑last‑breath, and a trend of relative tidal volume for adult patients.
Continuous predictive respiratory monitoring system (wearable thermal sensor with control unit and monitor)
A bedside system comprising a disposable thermal sensor, control unit, and monitor that continuously measures and displays respiratory rate, seconds‑since‑last‑breath, and a trend of relative tidal volume for adult patients.
Expertise Areas
- Continuous respiratory monitoring
- Clinical trial sponsorship and execution
- Medical device regulatory compliance (FDA 510(k))
- Wearable sensor development
Key Technologies
- Temperature‑based thermal sensing for respiration
- Wearable disposable sensors
- Real‑time respiratory signal processing
- Relative tidal volume estimation (trend)
News & Updates
Regulatory clearance documented as K240271 for a breathing frequency monitor; device indicated for adult patients in procedural areas and recovery rooms.
Selected to present as a finalist at the TechConnect World Innovation event.
Received a $100K MIPS award and launched a clinical study in collaboration with University of Maryland School of Medicine faculty.
Reported completion of study enrollment for a clinical investigation at The Ohio State University Wexner Medical Center.
Awarded a $2.4M SBIR Fasttrack grant from the National Heart, Lung, and Blood Institute.
Multiple press releases and articles documenting investments, awards, clinical studies, and regulatory milestones (examples include TEDCO investments and external press coverage).
Regulatory clearance documented as K240271 for a breathing frequency monitor; device indicated for adult patients in procedural areas and recovery rooms.
Selected to present as a finalist at the TechConnect World Innovation event.
Received a $100K MIPS award and launched a clinical study in collaboration with University of Maryland School of Medicine faculty.
Reported completion of study enrollment for a clinical investigation at The Ohio State University Wexner Medical Center.
Awarded a $2.4M SBIR Fasttrack grant from the National Heart, Lung, and Blood Institute.
Multiple press releases and articles documenting investments, awards, clinical studies, and regulatory milestones (examples include TEDCO investments and external press coverage).